These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 9082666)

  • 1. [Optimizing the lipid profile in secondary and primary prevention--is there still doubt after 4S, WOS and CARE?].
    Roskamm H
    Z Kardiol; 1996 Dec; 85(12):895-8. PubMed ID: 9082666
    [No Abstract]   [Full Text] [Related]  

  • 2. [Cholesterol lowering and life expectancy: a critical evaluation].
    Klepzig H; Kaltenbach M
    Z Kardiol; 1992 Jul; 81(7):347-53. PubMed ID: 1509792
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Cholesterol non-consensus in primary prevention of coronary heart disease. Methodologic problems in the interpretation of epidemiologic studies].
    Berger M
    Z Kardiol; 1993 Jul; 82(7):399-405. PubMed ID: 8379238
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rationale for and outline of the recommendations of the Working Group on Hypercholesterolemia and Other Dyslipidemias: interim report. Dyslipidemia Working Group of Health Canada.
    Frohlich J; Fodor G; McPherson R; Genest J; Langner N
    Can J Cardiol; 1998 Apr; 14 Suppl A():17A-21A. PubMed ID: 9594929
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Primary and secondary prevention of coronary disease by statins].
    Ferrières J
    Ann Cardiol Angeiol (Paris); 1999 Feb; 48(2):128-36. PubMed ID: 12555337
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lipid abnormalities and coronary heart disease.
    Grundy SM
    Clin Symp; 1997; 49(4):1-32. PubMed ID: 9444788
    [No Abstract]   [Full Text] [Related]  

  • 7. Aggressive medical therapy for the prevention and treatment of coronary artery disease.
    Malloy MJ; Kane JP
    Dis Mon; 1998 Jan; 44(1):1-40. PubMed ID: 9457050
    [No Abstract]   [Full Text] [Related]  

  • 8. Controversies in primary prevention among hyperlipidemic patients.
    McPherson R
    Can J Cardiol; 1999 Apr; 15 Suppl B():16B-19B. PubMed ID: 10350678
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The role of cholesterol-lowering drugs in prevention of coronary heart disease].
    Skałuba Z; Undas R
    Przegl Lek; 1998; 55(7-8):382-7. PubMed ID: 10021881
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Hypolipemic agents and prevention of coronary disease].
    Chadarevian R; Bruckert E; Turpin G
    Ann Cardiol Angeiol (Paris); 1997 Feb; 46(2):89-98. PubMed ID: 9137675
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Levels and criteria for evaluation of primary preventive interventions and their relevance for the cholesterol problem].
    Heyll U
    Z Kardiol; 1996 Mar; 85(3):166-70. PubMed ID: 8659194
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Lipids and primary prevention of coronary disease].
    Idzior-Waluś B
    Przegl Lek; 1998; 55(2):77-84. PubMed ID: 9695648
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Prevention of sudden death due to coronary disease].
    Spaulding C
    Bull Acad Natl Med; 1999; 183(8):1595-603; discussion 1603-5. PubMed ID: 10987052
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Decreasing cholesterol is life extending].
    Heinzl S
    Med Monatsschr Pharm; 1994 Dec; 17(12):357. PubMed ID: 7830697
    [No Abstract]   [Full Text] [Related]  

  • 15. High HDL Cholesterol Linked With Death in Coronary Artery Disease.
    Slomski A
    JAMA; 2022 Jul; 328(1):10. PubMed ID: 35788807
    [No Abstract]   [Full Text] [Related]  

  • 16. [Primary and secondary prevention in dyslipidemia in the elderly].
    Vogt A; Nieczaj R; Thomas HP; Borchelt M; Steinhagen-Thiessen E
    Ther Umsch; 2002 Jul; 59(7):341-4. PubMed ID: 12185949
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Active Lipid Management In Coronary Artery Disease (ALMICAD) study.
    Khanal S; Obeidat O; Hudson MP; Al-Mallah M; Bloome M; Lu M; Greenbaum AB; Kugelmass AD; Weaver WD
    Am J Med; 2007 Aug; 120(8):734.e11-7. PubMed ID: 17679135
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Assessment of the impact of fibrates and diet on survival and their cost-effectiveness: evidence from randomized, controlled trials in coronary heart disease and health economic evaluations.
    Montagne O; Vedel I; Durand-Zaleski I
    Clin Ther; 1999 Nov; 21(11):2027-35. PubMed ID: 10890271
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Coronary artery disease prevention: what's different for women?
    Bedinghaus J; Leshan L; Diehr S
    Am Fam Physician; 2001 Apr; 63(7):1393-400, 1405-6. PubMed ID: 11310652
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Statins in primary prevention of coronary heart disease].
    Paulweber B
    Wien Med Wochenschr; 1999; 149(5-6):129-38. PubMed ID: 10408004
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.